Tarsus Pharmaceuticals Inc (TARS)
Operating Cash Flow (Statement)
$79.70M
TTM · Period ending: · USD
TARS Operating Cash Flow (Statement)
Latest reported$79.70Mperiod ending
Latest reported$79.70Mperiod ending
TARS TTM Cash from Operations (-$1.97M → $79.70M)
TTM operating cash flow (statement)
High-resolution chart · PNG
TARS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 79,702,000 | |
| -16,452,000 | |
| -12,451,000 | |
| -53,963,000 | |
| -80,872,000 | |
| -65,889,000 | |
| -83,027,000 | |
| -100,180,000 | |
| -123,890,000 | |
| -133,312,000 | |
| -117,493,000 | |
| -89,032,000 | |
| -75,281,000 | |
| -55,714,000 | |
| -49,030,000 | |
| -50,277,000 | |
| -24,554,000 | |
| 256,000 | |
| 3,748,000 | |
| 5,856,000 | |
| -7,828,000 | |
| -30,936,000 | |
| -21,138,000 | |
| -11,931,000 | |
| -5,929,000 | |
| -3,667,750 | |
| -1,967,500 |